Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses

European Journal of Immunology

Volumn 46, Issue 8, 2016, Pages 2043-2053

  Stelzner, Kristin ^a   Herbert, Diana ^a   Popkova, Yulia ^a   Lorz, Axel ^a   Schiller, Jürgen ^a   Gericke, Martin ^a   Klöting, Nora ^a   Blüher, Matthias ^a   Franz, Sandra ^a   Simon, Jan C ^a   Saalbach, Anja ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Dendritic cells; Diet; Free fatty acids; Inflammation; Metabolism; TH1; TH17

Indexed keywords

FATTY ACID; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; OLEIC ACID; PALMITIC ACID;

ADAPTIVE IMMUNITY; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE MARROW DERIVED DENDRITIC CELL; CELL FUNCTION; CELL STIMULATION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DERMATITIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INDEPENDENT VARIABLE; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PSORIASIS; SENSITIZATION; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; WEIGHT GAIN;

EID: 84982190109     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201546263     Document Type: Article

References (68)

1. Jhun, J. Y., Yoon, B. Y., Park, M. K., Oh, H. J., Byun, J. K., Lee, S. Y., Min, J. K. et al., Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp. Mol. Med. 2012. 44: 424–431.
2. Louer, C. R., Furman, B. D., Huebner, J. L., Kraus, V. B., Olson, S. A. and Guilak, F., Diet-induced obesity significantly increases the severity of posttraumatic arthritis in mice. Arthritis Rheum. 2012. 64: 3220–3230.
3. Pini, M. and Fantuzzi, G., Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. J. Leukoc. Biol. 2010. 87: 51–58.
4. Pini, M., Sennello, J. A., Cabay, R. J. and Fantuzzi, G., Effect of diet-induced obesity on acute pancreatitis induced by administration of interleukin-12 plus interleukin-18 in mice. Obesity (Silver Spring) 2010. 18: 476–481.
5. Kanemaru, K., Matsuyuki, A., Nakamura, Y. and Fukami, K., Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice. Exp. Dermatol. 2015. 24: 436–442.
6. Wolk, K., Mallbris, L., Larsson, P., Rosenblad, A., Vingard, E. and Stahle, M., Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm. Venereol. 2009. 89: 492–497.
7. Shipman, A. R. and Millington, G. W., Obesity and the skin. Br. J. Dermatol. 2011. 165: 743–750.
8. Ghanim, H., Aljada, A., Hofmeyer, D., Syed, T., Mohanty, P. and Dandona, P., Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004. 110: 1564–1571.
9. Olefsky, J. M. and Glass, C. K., Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010. 72: 219–246.
10. Suganami, T., Nishida, J. and Ogawa, Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005. 25: 2062–2068.
11. Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S., Ishihara, A., Kanatani, A., Itadani, H. et al., Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 2003. 278: 46654–46660.
12. Wozniak, S. E., Gee, L. L., Wachtel, M. S. and Frezza, E. E., Adipose tissue: the new endocrine organ? A review article. Dig. Dis. Sci. 2009. 54: 1847–1856.
13. Boden, G., Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. 2008. 37: 635–6ix.
14. Boden, G., Obesity, insulin resistance and free fatty acids. Curr. Opin. Endocrinol. Diabetes Obes. 2011. 18: 139–143.
15. Bjorntorp, P., Bergman, H., and Varnauskas, E., Plasma free fatty acid turnover rate in obesity. Acta Med. Scand. 1969. 185: 351–356.
16. Opie, L. H. and Walfish, P. G., Plasma free fatty acid concentrations in obesity. N. Engl. J. Med. 1963. 268: 757–760.
17. Reaven, G. M., Hollenbeck, C., Jeng, C. Y., Wu, M. S. and Chen, Y. D., Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988. 37: 1020–1024.
18. Jensen, M. D., Haymond, M. W., Rizza, R. A., Cryer, P. E. and Miles, J. M., Influence of body fat distribution on free fatty acid metabolism in obesity. J. Clin. Invest. 1989. 83: 1168–1173.
19. Karpe, F., Dickmann, J. R. and Frayn, K. N., Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 2011. 60: 2441–2449.
20. Miller, M. R., Pereira, R. I., Langefeld, C. D., Lorenzo, C., Rotter, J. I., Chen, Y. D., Bergman, R. N. et al., Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: the IRAS Family Study. J. Clin. Endocrinol. Metab. 2012. 97: 3285–3291.
21. Nielsen, S., Guo, Z., Albu, J. B., Klein, S., O'Brien, P. C. and Jensen, M. D., Energy expenditure, sex, and endogenous fuel availability in humans. J. Clin. Invest. 2003. 111: 981–988.
22. Calder, P. C., Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013. 75: 645–662.
23. Estruch, R., Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study. Proc. Nutr. Soc. 2010. 69: 333–340.
24. Guasch-Ferre, M., Hu, F. B., Martinez-Gonzalez, M. A., Fito, M., Bullo, M., Estruch, R., Ros, E. et al., Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014. 12: 1–11.
25. Yates, C. M., Calder, P. C. and Ed, R. G., Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol. Ther. 2014. 141: 272–282.
26. Qin, S., Wen, J., Bai, X. C., Chen, T. Y., Zheng, R. C., Zhou, G. B., Ma, J. et al., Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis. Mol. Med. Rep. 2014. 9: 2097–2104.
27. Georgiadi, A. and Kersten, S., Mechanisms of gene regulation by fatty acids. Adv. Nutr. 2012. 3: 127–134.
28. Lee, J. Y., Sohn, K. H., Rhee, S. H. and Hwang, D., Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001. 276: 16683–16689.
29. Frommer, K. W., Schaffler, A., Rehart, S., Lehr, A., Muller-Ladner, U. and Neumann, E., Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann. Rheum. Dis. 2015. 74: 303–310.
30. Lee, J. Y., Zhao, L., Youn, H. S., Weatherill, A. R., Tapping, R., Feng, L., Lee, W. H. et al., Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 2004. 279: 16971–16979.
31. Leiguez, E., Giannotti, K. C., Moreira, V., Matsubara, M. H., Gutierrez, J. M., Lomonte, B., Rodriguez, J. P. et al., Critical role of TLR2 and MyD88 for functional response of macrophages to a group IIA-secreted phospholipase A2 from snake venom. PLoS One 2014. 9: e93741.
32. Reynolds, C. M., McGillicuddy, F. C., Harford, K. A., Finucane, O. M., Mills, K. H. and Roche, H. M., Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol. Nutr. Food Res. 2012. 56: 1212–1222.
33. Snodgrass, R. G., Huang, S., Choi, I. W., Rutledge, J. C. and Hwang, D. H., Inflammasome-mediated secretion of IL-1beta in human monocytes through TLR2 activation; modulation by dietary fatty acids. J. Immunol. 2013. 191: 4337–4347.
34. Steinbrink, K., Mahnke, K., Grabbe, S., Enk, A. H. and Jonuleit, H., Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance? Hum. Immunol. 2009. 70: 289–293.
35. Dalod, M., Chelbi, R., Malissen, B. and Lawrence, T., Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J. 2014. 33: 1104–1116.
36. Mueller, S. N. and Germain, R. N., Stromal cell contributions to the homeostasis and functionality of the immune system. Nat. Rev. Immunol. 2009. 9: 618–629.
37. Yamazaki, S. and Steinman, R. M., Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. J. Dermatol. Sci. 2009. 54: 69–75.
38. Kong, W., Yen, J. H., Vassiliou, E., Adhikary, S., Toscano, M. G. and Ganea, D., Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family. Lipids Health Dis. 2010. 9: 1–10.
39. Weatherill, A. R., Lee, J. Y., Zhao, L., Lemay, D. G., Youn, H. S. and Hwang, D. H., Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 2005. 174: 5390–5397.
40. Zapata-Gonzalez, F., Rueda, F., Petriz, J., Domingo, P., Villarroya, F., Diaz-Delfin, J., de Madariaga, M. A. et al., Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J. Leukoc. Biol. 2008. 84: 1172–1182.
41. Huang, S., Rutkowsky, J. M., Snodgrass, R. G., Ono-Moore, K. D., Schneider, D. A., Newman, J. W., Adams, S. H. et al., Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 2012. 53: 2002–2013.
42. Blaak, E. E., Hul, G., Verdich, C., Stich, V., Martinez, J. A., Petersen, M., Feskens, E. F. et al., Impaired fat-induced thermogenesis in obese subjects: the NUGENOB study. Obesity (Silver Spring) 2007. 15: 653–663.
43. Soriguer, F., Garcia-Serrano, S., Garcia-Almeida, J. M., Garrido-Sanchez, L., Garcia-Arnes, J., Tinahones, F. J., Cardona, I. et al., Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test. Obesity (Silver Spring) 2009. 17: 10–15.
44. van der Fits, L., Mourits, S., Voerman, J. S., Kant, M., Boon, L., Laman, J. D., Cornelissen, F. et al., Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 2009. 182: 5836–5845.
45. Boulet, L. P., Asthma and obesity. Clin. Exp. Allergy 2013. 43: 8–21.
46. Davidovici, B. B., Sattar, N., Prinz, J. C., Puig, L., Emery, P., Barker, J. N., van de, K. P. et al., Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J. Invest. Dermatol. 2010. 130: 1785–1796.
47. Gremese, E., Tolusso, B., Gigante, M. R. and Ferraccioli, G., Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Front. Immunol. 2014. 5: 1–10.
48. Hedstrom, A. K., Olsson, T. and Alfredsson, L., Body mass index during adolescence, rather than childhood, is critical in determining MS risk. Mult. Scler. 2015. DOI: 10.1177/1352458515603798.
49. Puig, L., Obesity and psoriasis: body weight and body mass index influence the response to biological treatment. J. Eur. Acad. Dermatol. Venereol. 2011. 25: 1007–1011.
50. Setty, A. R., Curhan, G. and Choi, H. K., Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch. Intern. Med. 2007. 167: 1670–1675.
51. de Jong, A. J., Kloppenburg, M., Toes, R. E. and Ioan-Facsinay, A., Fatty acids, lipid mediators, and T-cell function. Front. Immunol. 2014. 5: 483.
52. Frohnert, B. I., Jacobs, D. R., Jr., Steinberger, J., Moran, A., Steffen, L. M. and Sinaiko, A. R., Relation between serum free fatty acids and adiposity, insulin resistance, and cardiovascular risk factors from adolescence to adulthood. Diabetes 2013. 62: 3163–3169.
53. Tuvdendorj, D., Chandalia, M., Batbayar, T., Saraf, M., Beysen, C., Murphy, E. J. and Abate, N., Altered subcutaneous abdominal adipose tissue lipid synthesis in obese, insulin-resistant humans. Am. J. Physiol. Endocrinol. Metab. 2013. 305: E999–E1006.
54. Wong, S. W., Kwon, M. J., Choi, A. M., Kim, H. P., Nakahira, K. and Hwang, D. H., Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009. 284: 27384–27392.
55. Nguyen, M. T., Favelyukis, S., Nguyen, A. K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R. et al., A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 2007. 282: 35279–35292.
56. Chang, C. F., Chau, Y. P., Kung, H. N. and Lu, K. S., The lipopolysaccharide-induced pro-inflammatory response in RAW264.7 cells is attenuated by an unsaturated fatty acid-bovine serum albumin complex and enhanced by a saturated fatty acid-bovine serum albumin complex. Inflamm. Res. 2012. 61: 151–160.
57. Suganami, T., Mieda, T., Itoh, M., Shimoda, Y., Kamei, Y. and Ogawa, Y., Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem. Biophys. Res. Commun. 2007. 354: 45–49.
58. Re, F. and Strominger, J. L., Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 2001. 276: 37692–37699.
59. Vassiliou, E. K., Gonzalez, A., Garcia, C., Tadros, J. H., Chakraborty, G. and Toney, J. H., Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems. Lipids Health Dis. 2009. 8: 1–10.
60. Carluccio, M. A., Massaro, M., Bonfrate, C., Siculella, L., Maffia, M., Nicolardi, G., Distante, A. et al., Oleic acid inhibits endothelial activation : A direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet. Arterioscler. Thromb. Vasc. Biol. 1999. 19: 220–228.
61. Schlich, R., Lamers, D., Eckel, J. and Sell, H., Adipokines enhance oleic acid-induced proliferation of vascular smooth muscle cells by inducing CD36 expression. Arch. Physiol. Biochem. 2015. 121: 81–87.
62. Wu, H. T., Chen, W., Cheng, K. C., Ku, P. M., Yeh, C. H. and Cheng, J. T., Oleic acid activates peroxisome proliferator-activated receptor delta to compensate insulin resistance in steatotic cells. J. Nutr. Biochem. 2012. 23: 1264–1270.
63. Kloting, N., Fasshauer, M., Dietrich, A., Kovacs, P., Schon, M. R., Kern, M., Stumvoll, M. et al., Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 2010. 299: E506–E515.
64. Chen, S., Hoene, M., Li, J., Li, Y., Zhao, X., Haring, H. U., Schleicher, E. D. et al., Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry. J. Chromatogr. A 2013. 1298: 9–16.
65. Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. and Schwudke, D., Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 2008. 49: 1137–1146.
66. Eibisch, M., Suss, R. and Schiller, J., Time-dependent intensity changes of free fatty acids detected by matrix-assisted laser desorption and ionization time-of-flight mass spectrometry in the presence of 1,8-bis-(dimethylamino)naphthalene–a cautionary note. Rapid Commun. Mass Spectrom. 2012. 26: 1573–1576.
67. Eibisch, M., Popkova, Y., Suss, R., Schiller, J. and Dannenberger, D., Evaluation of a commercial enzymatic test kit regarding the quantitative analysis of different free fatty acids. Anal. Bioanal. Chem. 2014. 406: 7401–7405.
68. Saalbach, A., Janik, T., Busch, M., Herbert, D., Anderegg, U. and Simon, J. C., Fibroblasts support migration of monocyte-derived dendritic cells by secretion of PGE and MMP-1. Exp. Dermatol. 2015. 24: 598–604.